Arcturus, JNJ to develop nucleic acids to treat HBV

By Allison Johnson | Oct 27, 2017 | 9:43 PM GMT

Arcturus Therapeutics Inc. (San Diego, Calif.) and the Janssen Pharmaceuticals Inc. unit of Johnson & Johnson (NYSE:JNJ) partnered to